Winrevair (sotatercept-csrk) - BMS, Merck (MSD)
Sotatercept in Pediatric Pulmonary Hypertension: Experience from the Pediatric Pulmonary Hypertension Network. (PubMed, Chest) - Oct 6, 2026 - "Pediatric PH patients treated with sotatercept as add-on therapy demonstrated improvement in functional class and other PH disease indicators and was generally well tolerated." 
Journal • Cardiovascular • Hypertension • Pediatrics • Pulmonary Arterial Hypertension • Pulmonary Disease • Respiratory Diseases • Transplantation • TGFB1
http://www.ncbi.nlm.nih.gov/pubmed/42833549
 
Andrea L Jones; Benjamin S Frank; Catherine M Avitabile; Claire Parker; Dephine Yung; Dunbar D Ivy; Edward Kirkpatrick; Emily P Williams; Eric D Austin; Erika B Rosenzweig; Mary P Mullen; Megan Griffiths; Meredith J O'Neil; Neelam D Bhatt; Nidhy P Varghese; Patrick D Evers; Paul J Critser; Rachel Capote; Rachel T Sullivan; Stephanie S Handler; Usha S Krishnan
 
Oct 6, 2026
 
Prev Next